- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02559726
Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response (HSYNC)
Identification and Quantification of a Mechanical Hyper-synchronicity State in Hypertrophic Cardiomyopathy (HCM) With Left Outflow-tract Obstruction and Description of Its Electrical and Electro-mechanical Characteristics Thanks to an Innovative Multi-imaging Approach to Predict a Positive Response to Dual Chamber Pacing. The Hsync Study.
Hypertrophic cardiomyopathy (HCM) is a common genetic cardiovascular disease. Outflow-tract gradient of 30 mmHg or more under resting conditions is an independent determinant of symptoms of progressive heart failure and death.
The investigators hypothesize that the electrical approach by dual chamber pacing could improve symptoms and reduce outflow-tract obstruction in a specific sub-group of selected patients with a mechanical hyper-synchronicity. The aim of the study is to identify and describe this phenomenon in HCM with (O-HCM) and without (NO-HCM) outflow-tract obstruction thanks to innovative multi-imaging approach.
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bordeaux, France, 33000
- CHU de Bordeaux
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- HCM: Adults aged more than 18 years with sarcomeric hypertrophic cardiomyopathy under optimal medical therapy, isolated septal hypertrophy, sinus rhythm, exploitable acoustic window. For women of childbearing age, effective contraception and required negative pregnancy test.
- O-HCM : outflow-tract gradient more than 30 mmHg at rest and during exercise
- NO-HCM : outflow-tract gradient less than 30 mmHg at rest and during exercise
- HV: Adults aged more than 18 years, without cardiovascular disease. For women of childbearing age, effective contraception and required negative pregnancy test.
Exclusion Criteria:
- HV: unusable acoustic window
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: O-HCM
20 patients with Hypertrophic Cardiomyopathy with outflow-tract obstruction
|
Other Names:
|
Experimental: NO-HCM
20 patients with Hypertrophic Cardiomyopathy without outflow-tract obstruction
|
Other Names:
|
Other: healthy volunteers
20 healthy volunteers
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mechanical time delay in contraction between basal and apical walls in TEE and MRI in O-HCM, NO-HCM and healthy volunteers
Time Frame: Day 1
|
The main interest variable is the delay value (ms) of the contraction between basal and apical walls measured by TEE and MRI.
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Relationship between each mesure with hyper-synchronicity and outflow-tract gradient
Time Frame: Day 1
|
Day 1
|
Electrical time delay in ECM between basal and apical walls and relationship with hyper-synchronicity and outflow tract gradient.
Time Frame: Day 1
|
Day 1
|
Mechanical time delay between septal and lateral walls in MRI and TEE.
Time Frame: Day 1
|
Day 1
|
Evolution of mechanical time delay between basal and apical walls at rest and exercise in O-HCM and NO-HCM and relationship with outflow-tract gradient.
Time Frame: Day 1
|
Day 1
|
Delay between peaks of basal and apical radial displacement in MRI
Time Frame: Day 1
|
Day 1
|
Delay between the beginning of the apical and basal radial displacement in MRI
Time Frame: Day 1
|
Day 1
|
Apical-basal phase on a phase analysis of the radial displacement data in MRI
Time Frame: Day 1
|
Day 1
|
Delay between apical and basal peaks circumferential strain in MRI
Time Frame: Day 1
|
Day 1
|
Delay between the beginning of the apical and basal circumferential deformation in MRI
Time Frame: Day 1
|
Day 1
|
Twist angle between the base and the apex in MRI
Time Frame: Day 1
|
Day 1
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Claire CORNOLLE, Dr, University Hospital, Bordeaux
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHUBX 2014/06
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertrophic Cardiomyopathy
-
French Cardiology SocietyCompleted1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy | 2- Obstructive Hypertrophic Cardiomyopathy | 3- Non Obstructive Hypertrophic CardiomyopathyFrance
-
Montreal Heart InstituteCanadian Institutes of Health Research (CIHR)Enrolling by invitationCardiomyopathies | Hypertrophic Cardiomyopathy | Hypertrophic Obstructive Cardiomyopathy | Familial Hypertrophic CardiomyopathyCanada
-
Bristol-Myers SquibbActive, not recruitingHypertrophic Cardiomyopathy | Non-obstructive Hypertrophic Cardiomyopathy | Obstructive Hypertrophic CardiomyopathyDenmark, United States, Belgium, Czechia, France, Germany, Israel, Italy, Netherlands, Poland, Portugal, Spain, United Kingdom
-
University of Sao PauloCompletedNon-obstructive Hypertrophic Cardiomyopathy | Obstructive Hypertrophic CardiomyopathyBrazil
-
Shandong Suncadia Medicine Co., Ltd.RecruitingObstructive Hypertrophic CardiomyopathyChina
-
Morten Steen Kvistholm JensenOdense University Hospital; Zealand University Hospital; Rigshospitalet, Denmark and other collaboratorsRecruitingNon-obstructive Hypertrophic CardiomyopathyDenmark
-
Imperial College LondonBritish Heart FoundationRecruitingHypertrophic Cardiomyopathy | Hypertrophic Obstructive CardiomyopathyUnited Kingdom
-
St. Antonius HospitalErasmus Medical CenterRecruitingHypertrophic CardiomyopathyNetherlands
-
CytokineticsCompletedHypertrophic Cardiomyopathy (HCM)United States, Spain, Italy, Netherlands
-
MyoKardia, Inc.CompletedObstructive Hypertrophic CardiomyopathyUnited States, France, Germany, Czechia, Spain, Belgium, Denmark, Portugal, Netherlands, Israel, Poland, United Kingdom, Italy
Clinical Trials on Echocardiography (TEE)
-
Far Eastern Memorial HospitalCompletedOut-Of-Hospital Cardiac ArrestTaiwan
-
The Cleveland ClinicCompletedAtrial FibrillationUnited States
-
NYU Langone HealthCompleted
-
Medical Centre LeeuwardenOnze Lieve Vrouwe GasthuisNot yet recruiting
-
Hospital Raja Permaisuri BainunUniversity of Malaya; Hospital Queen Elizabeth, Malaysia; Kuala Lumpur General... and other collaboratorsRecruiting
-
Yonsei UniversityCompletedVideo-assisted Thoracic SurgeryKorea, Republic of
-
Milton S. Hershey Medical CenterCompletedEchocardiography, Transesophageal | Ventricular Function, RightUnited States
-
Weill Medical College of Cornell UniversityWithdrawn3D Transesophageal and Transthoracic EchocardiogramUnited States
-
Maisonneuve-Rosemont HospitalUnknownPeripheral Arterial Disease | Aortic AneurysmCanada
-
Medical University of ViennaUnknownVentricular Function, LeftAustria